Functions of Antibodies
暂无分享,去创建一个
[1] P. Sansonetti,et al. Secretory component: a new role in secretory IgA-mediated immune exclusion in vivo. , 2002, Immunity.
[2] R. Lawrence,et al. A role for antibody and Fc receptor in the clearance of Brugia malayi microfilariae , 2002, European journal of immunology.
[3] M. Renedo,et al. FcγR receptors activate MAP kinase and up‐regulate the cyclooxygenase pathway without increasing arachidonic acid release in monocytic cells , 2002, European journal of immunology.
[4] A. Capron,et al. Immunoglobulin E and effector cells in schistosomiasis. , 1994, Science.
[5] J. Sheehan,et al. Functional and neutralization profile of seven overlapping antigenic sites on the HN glycoprotein of Newcastle disease virus: monoclonal antibodies to some sites prevent viral attachment. , 1989, Virus research.
[6] S. Tzipori,et al. Molecular Cloning and Expression of a Gene EncodingCryptosporidium parvum Glycoproteins gp40 and gp15 , 2000, Infection and Immunity.
[7] G. Pier,et al. Evaluation of Flagella and Flagellin of Pseudomonas aeruginosa as Vaccines , 2009, Infection and Immunity.
[8] J. Rowatt,et al. Antibody-dependent cellular cytotoxicity of Coxiella burnetii-infected J774 macrophage target cells , 1984, Infection and immunity.
[9] L. Nencioni,et al. IgA-driven antibacterial activity against Streptococcus pneumoniae by mouse lung lymphocytes. , 1988, The American review of respiratory disease.
[10] D. Mosher,et al. Ail Protein Binds Ninth Type III Fibronectin Repeat (9FNIII) within Central 120-kDa Region of Fibronectin to Facilitate Cell Binding by Yersinia pestis* , 2012, The Journal of Biological Chemistry.
[11] C. Hahn,et al. Heteropolymer‐mediated clearance of immune complexes via erythrocyte CR1: mechanisms and applications , 2001, Immunological reviews.
[12] R. Davey,et al. T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus , 2011, Proceedings of the National Academy of Sciences.
[13] J. Macaskill,et al. Immunological clearance of 75Se-labelled Trypanosoma brucei in mice. II. Mechanisms in immune animals. , 1980, Immunology.
[14] R. Carter,et al. Transmission‐blocking antibodies against multiple, non‐variant target epitopes of the Plasmodium falciparum gamete surface antigen Pfs230 are all complement‐fixing , 1994, Parasite immunology.
[15] R. Horton,et al. Antibodies and Their Receptors: Different Potential Roles in Mucosal Defense , 2013, Front. Immunol..
[16] D. Granoff,et al. Ex Vivo Model of Meningococcal Bacteremia Using Human Blood for Measuring Vaccine-Induced Serum Passive Protective Activity , 2009, Clinical and Vaccine Immunology.
[17] I. Williams,et al. Extensive complement-dependent enhancement of HIV-1 by autologous non-neutralising antibodies at early stages of infection , 2011, Retrovirology.
[18] J. Donnelly,et al. Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease. , 2009, Vaccine.
[19] A. Casadevall,et al. Serum therapy revisited: animal models of infection and development of passive antibody therapy , 1994, Antimicrobial Agents and Chemotherapy.
[20] D. Musher,et al. Association Between FcγRIIa-R131 Allotype and Bacteremic Pneumococcal Pneumonia , 2000 .
[21] A. Schlageter,et al. Opsonization of Cryptococcus neoformans by a family of isotype-switch variant antibodies specific for the capsular polysaccharide , 1990, Infection and immunity.
[22] S. Akira,et al. Toll-like Receptor 9–Dependent and –Independent Dendritic Cell Activation by Chromatin–Immunoglobulin G Complexes , 2004, The Journal of experimental medicine.
[23] Y. Mikyas,et al. Postentry Neutralization of Adenovirus Type 5 by an Antihexon Antibody , 2004, Journal of Virology.
[24] J. Skehel,et al. An antibody that prevents the hemagglutinin low pH fusogenic transition. , 2002, Virology.
[25] J. Ravetch,et al. Fc receptors initiate the Arthus reaction: redefining the inflammatory cascade. , 1994, Science.
[26] M. Mazanec,et al. Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies , 1995, Journal of virology.
[27] G. Nybakken,et al. West Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibody , 2006, Proceedings of the National Academy of Sciences.
[28] S. Bacchetti,et al. Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2 , 1982, Infection and immunity.
[29] L. Luzzatto,et al. Early phagocytosis of glucose-6-phosphate dehydrogenase (G6PD)-deficient erythrocytes parasitized by Plasmodium falciparum may explain malaria protection in G6PD deficiency. , 1998, Blood.
[30] R. Heinzen,et al. Antibody-mediated immunity to the obligate intracellular bacterial pathogen Coxiella burnetii is Fc receptor- and complement-independent , 2009, BMC Immunology.
[31] J. Kappes,et al. The Role of Natural Killer (NK) Cells and NK Cell Receptor Polymorphisms in the Assessment of HIV-1 Neutralization , 2012, PloS one.
[32] A. Capron,et al. IgE antibody-mediated cytotoxicity of rat macrophages against microfilaria of Dipetalonema citeae in vitro. , 1980, Clinical and experimental immunology.
[33] G. Parks,et al. Differential mechanisms of complement-mediated neutralization of the closely related paramyxoviruses simian virus 5 and mumps virus. , 2008, Virology.
[34] R. Discipio,et al. The role of the complement anaphylatoxins in the recruitment of eosinophils. , 2007, International immunopharmacology.
[35] M. McConnell,et al. Role of Fibronectin in the Adhesion of Acinetobacter baumannii to Host Cells , 2012, PloS one.
[36] P. Ricciardi-Castagnoli,et al. Fcγ Receptor–mediated Induction of Dendritic Cell Maturation and Major Histocompatibility Complex Class I–restricted Antigen Presentation after Immune Complex Internalization , 1999, The Journal of experimental medicine.
[37] B. Trus,et al. Two antibodies that neutralize papillomavirus by different mechanisms show distinct binding patterns at 13 A resolution. , 1998, Journal of molecular biology.
[38] Berzins,et al. Antigenic Diversity of Plasmodium falciparum and Antibody‐Mediated Parasite Neutralization , 2000, Scandinavian journal of immunology.
[39] D. Granoff,et al. Bactericidal and opsonic activity of IgG1 and IgG2 anticapsular antibodies to Haemophilus influenzae type b. , 1990, The Journal of infectious diseases.
[40] M. Carroll,et al. The complement system in regulation of adaptive immunity , 2004, Nature Immunology.
[41] D. Salmon,et al. Role of immune serum and complement in stimulation of the metabolic burst of human neutrophils by Plasmodium falciparum , 1986, Infection and immunity.
[42] J. Kazura. Host defense mechanisms against nematode parasites: destruction of newborn Trichinella spiralis larvae by human antibodies and granulocytes. , 1981, The Journal of infectious diseases.
[43] R. Hernandez,et al. Sindbis Virus Conformational Changes Induced by a Neutralizing Anti-E1 Monoclonal Antibody , 2008, Journal of Virology.
[44] C. Mannella,et al. The bactericidal effect of a complement-independent antibody is osmolytic and specific to Borrelia , 2009, Proceedings of the National Academy of Sciences.
[45] J. Mak,et al. Immune responses in human Brugia malayi infections: serum dependent cell-mediated destruction of infective larvae in vitro. , 1982, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[46] M. Reitz,et al. Intracellular expression of antibody fragments directed against HIV reverse transcriptase prevents HIV infection in vitro , 1995, Nature Medicine.
[47] G. Marshall,et al. The biology and future prospects of antivirulence therapies , 2008, Nature Reviews Microbiology.
[48] P. Lydyard,et al. Induction of tumor necrosis factor alpha production by adhered human monocytes: a key role for Fcgamma receptor type IIIa in rheumatoid arthritis. , 2000, Arthritis and rheumatism.
[49] N. Bourne,et al. Antibody-mediated protection against genital herpes simplex virus type 2 disease in mice by Fc gamma receptor-dependent and -independent mechanisms. , 2007, Journal of reproductive immunology.
[50] N. Dimmock,et al. Hemagglutinin 1-Specific Immunoglobulin G and Fab Molecules Mediate Postattachment Neutralization of Influenza A Virus by Inhibition of an Early Fusion Event , 2001, Journal of Virology.
[51] D. Burton,et al. Fc receptor but not complement binding is important in antibody protection against HIV , 2007, Nature.
[52] T. Out,et al. Fc gamma receptor IIa (CD32) polymorphism in fulminant meningococcal septic shock in children. , 1994, The Journal of infectious diseases.
[53] D. Metzger,et al. Fc Receptor-Mediated Phagocytosis Makes a Significant Contribution to Clearance of Influenza Virus Infections1 , 2001, The Journal of Immunology.
[54] E. Daar,et al. Antibody from Patients with Acute Human Immunodeficiency Virus (HIV) Infection Inhibits Primary Strains of HIV Type 1 in the Presence of Natural-Killer Effector Cells , 2001, Journal of Virology.
[55] G. Landucci,et al. In vitro reduction of virus infectivity by antibody-dependent cell-mediated immunity. , 1998, Journal of immunological methods.
[56] S. Bradley,et al. Ontogeny of the immune response. IV. The role of antigen elimination in the true primary immune response in germfree, colostrum-deprived piglets. , 1967, Journal of immunology.
[57] S. Rottem,et al. Adhesion and biofilm formation of Mycoplasma pneumoniae on an abiotic surface , 2011, Archives of Microbiology.
[58] B. Prasad,et al. Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb. , 2002, The Journal of clinical investigation.
[59] R. Sauerwein,et al. Transmission blockade of Plasmodium falciparum malaria by anti-Pfs230-specific antibodies is isotype dependent , 1995, Infection and immunity.
[60] D. Bout,et al. Interaction between ToxoplasmaGondii and Enterocyte , 1999 .
[61] S. Langermann,et al. Development of a recombinant FimCH vaccine for urinary tract infections. , 2003, Advances in experimental medicine and biology.
[62] D. Musher,et al. Association between FcgammaRIIa-R131 allotype and bacteremic pneumococcal pneumonia. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[63] H. Lillehoj,et al. Intestinal immune responses to coccidiosis. , 2000, Developmental and comparative immunology.
[64] L. Lopalco,et al. CCR5-Reactive Antibodies in Seronegative Partners of HIV-Seropositive Individuals Down-Modulate Surface CCR5 In Vivo and Neutralize the Infectivity of R5 Strains of HIV-1 In Vitro1 , 2000, The Journal of Immunology.
[65] S. Zolla-Pazner,et al. Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1 , 1995, The Journal of experimental medicine.
[66] D. McFarlin,et al. Detection of cell-dependent cytotoxic antibody to cells infected with herpes simplex virus , 1974, Nature.
[67] Michael J. Davis,et al. X-Linked Immunodeficient Mice Exhibit Enhanced Susceptibility to Cryptococcus neoformans Infection , 2013, mBio.
[68] B. Benacerraf,et al. Blood clearance of P32-labeled vesicular stomatitis and Newcastle disease viruses by the reticuloendothelial system in mice. , 1960, Journal of immunology.
[69] L. James,et al. Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21) , 2010, Proceedings of the National Academy of Sciences.
[70] M. Trudel,et al. Involvement of the complement system in the protection of mice from challenge with respiratory syncytial virus Long strain following passive immunization with monoclonal antibody 18A2B2 , 1996, Vaccine.
[71] R. Rappuoli,et al. Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity. , 2003, The Journal of infectious diseases.
[72] L. Nencioni,et al. IgA-dependent cell-mediated activity against enteropathogenic bacteria: distribution, specificity, and characterization of the effector cells. , 1984, Journal of immunology.
[73] M. Capron,et al. Antibody response of Schistosoma mansoni-infected human subjects to the recombinant P28 glutathione-S-transferase and to synthetic peptides , 1990, Journal of clinical microbiology.
[74] D. M. Lupan,et al. Passive immunization against Cryptococcus neoformans with an isotype-switch family of monoclonal antibodies reactive with cryptococcal polysaccharide , 1990, Infection and immunity.
[75] A. Bohbot,et al. Involvement of Fc gamma RI (CD64) in the mechanism of HIV-1 inhibition by polyclonal IgG purified from infected patients in cultured monocyte-derived macrophages. , 2004, Journal of immunology.
[76] Y. Yuthavong,et al. Increased susceptibility of malaria-infected variant erythrocytes to the mononuclear phagocyte system. , 1990, Blood cells.
[77] T. Burkot,et al. Target antigens of transmission-blocking immunity on gametes of plasmodium falciparum , 1983, The Journal of experimental medicine.
[78] M. Wong,et al. FcgammaRIIA polymorphisms in Streptococcus pneumoniae infection. , 2003, Immunology and cell biology.
[79] D. R. Anderson,et al. Targeted anti-cancer therapy using rituximab, a chimaeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin's B-cell lymphoma. , 1997, Biochemical Society transactions.
[80] J. V. D. van de Winkel,et al. A single amino acid in the second Ig-like domain of the human Fc gamma receptor II is critical for human IgG2 binding. , 1991, Journal of immunology.
[81] M. Dziegiel,et al. A Novel Antibody-Dependent Cellular Cytotoxicity Mechanism Involved in Defense against Malaria Requires Costimulation of Monocytes FcγRII and FcγRIII1 , 2007, The Journal of Immunology.
[82] A. Celada,et al. Opsonic activity of human immune serum on in vitro phagocytosis of Plasmodium falciparum infected red blood cells by monocytes. , 1982, Clinical and experimental immunology.
[83] R. Sindhu,et al. Antibody-dependent cell-mediated effects in bancroftian filariasis. , 1981, Immunology.
[84] M. Sliwkowski,et al. Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin). , 1999, Seminars in oncology.
[85] L. Rönnblom,et al. Induction of interferon-alpha by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sjögren's syndrome autoantigen-associated RNA. , 2006, Arthritis and rheumatism.
[86] P. Auewarakul,et al. Identification of prohibitin as a Chikungunya virus receptor protein , 2012, Journal of medical virology.
[87] M. Ouattara,et al. Resistance to Schistosoma mansoni in humans: influence of the IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy. , 1993, The Journal of infectious diseases.
[88] S. Wahl,et al. Polyreactive Antibodies Plus Complement Enhance the Phagocytosis of Cells Made Apoptotic by UV-Light or HIV , 2013, Scientific Reports.
[89] A. Shiratsuchi,et al. Evidence for Phagocytosis of Influenza Virus-Infected, Apoptotic Cells by Neutrophils and Macrophages in Mice1 , 2007, The Journal of Immunology.
[90] N. Dimmock,et al. Neutralization of animal virus infectivity by antibody , 2007, Archives of Virology.
[91] Sakae Tanaka,et al. Fcγ receptor signaling in primary human microglia: differential roles of PI‐3K and Ras/ERK MAPK pathways in phagocytosis and chemokine induction , 2004, Journal of leukocyte biology.
[92] P. Brioen,et al. Neutralization of poliovirus by antibody-mediated polymerization. , 1983, Virology.
[93] J. Mcghee,et al. Function of anti-Streptococcus mutans antibodies: anti-ribosomal antibodies inhibit acid production, growth, and glucose phosphotransferase activity , 1984, Infection and Immunity.
[94] D. Mosser,et al. The influence of IgG density and macrophage Fc (gamma) receptor cross-linking on phagocytosis and IL-10 production. , 2010, Immunology letters.
[95] M. Dziegiel,et al. A novel antibody-dependent cellular cytotoxicity mechanism involved in defense against malaria requires costimulation of monocytes FcgammaRII and FcgammaRIII. , 2007, Journal of immunology.
[96] J. Ravetch,et al. Fcgamma receptors as regulators of immune responses. , 2008, Nature reviews. Immunology.
[97] A. Capron,et al. A new function for platelets: IgE-dependent killing of schistosomes , 1983, Nature.
[98] A. Cravioto,et al. Antigen Detection in EnteropathogenicEscherichia coli Using Secretory Immunoglobulin A Antibodies Isolated from Human Breast Milk , 2000, Infection and Immunity.
[99] J. Dankert,et al. Association of human Fc gamma RIIa (CD32) polymorphism with susceptibility to and severity of meningococcal disease. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[100] M. Perkins,et al. Sialic acid-dependent binding of Plasmodium falciparum merozoite surface antigen, Pf200, to human erythrocytes. , 1988, Journal of immunology.
[101] A. Ferrante,et al. The role of complement, antibody, and tumor necrosis factor alpha in the killing of Plasmodium falciparum by the monocytic cell line THP-1 , 1997, Infection and immunity.
[102] T. Bergström,et al. Glycoprotein G of Herpes Simplex Virus 2 as a Novel Vaccine Antigen for Immunity to Genital and Neurological Disease , 2012, Journal of Virology.
[103] M. Diamond,et al. Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus. , 2003, Viral immunology.
[104] T. Cate,et al. Microneutralization test for influenza A and B and parainfluenza 1 and 2 viruses that uses continuous cell lines and fresh serum enhancement , 1980, Journal of clinical microbiology.
[105] P. Brandtzaeg. Induction of secretory immunity and memory at mucosal surfaces. , 2007, Vaccine.
[106] S. Levy,et al. Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity , 2003, Nature Medicine.
[107] G. Pietersz,et al. Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond , 2012, Nature Reviews Drug Discovery.
[108] Subhash G. Vasudevan,et al. Ligation of Fc gamma receptor IIB inhibits antibody-dependent enhancement of dengue virus infection , 2011, Proceedings of the National Academy of Sciences.
[109] L. Nencioni,et al. Antibody-dependent cell-mediated antibacterial activity of intestinal lymphocytes with secretory IgA , 1983, Nature.
[110] M. Pichichero,et al. Vaccine candidates PhtD and PhtE of Streptococcus pneumoniae are adhesins that elicit functional antibodies in humans. , 2012, Vaccine.
[111] D. Fremont,et al. Antibody Recognition of Cell Surface-Associated NS1 Triggers Fc-γ Receptor-Mediated Phagocytosis and Clearance of West Nile Virus-Infected Cells , 2007, Journal of Virology.
[112] J. V. D. van de Winkel,et al. Crucial role of FcgammaRIIa (CD32) in assessment of functional anti-Streptococcus pneumoniae antibody activity in human sera. , 1999, The Journal of infectious diseases.
[113] S. Zolla-Pazner,et al. Nonneutralizing Antibodies Are Able To Inhibit Human Immunodeficiency Virus Type 1 Replication in Macrophages and Immature Dendritic Cells , 2006, Journal of Virology.
[114] F. Mooi,et al. Targeting to Fcgamma receptors, but not CR3 (CD11b/CD18), increases clearance of Bordetella pertussis. , 2001, The Journal of infectious diseases.
[115] D. Forthal,et al. Fc receptor-mediated antiviral antibodies , 2009, Current opinion in HIV and AIDS.
[116] Kevin Marsh,et al. Targets of antibodies against Plasmodium falciparum-infected erythrocytes in malaria immunity. , 2012, The Journal of clinical investigation.
[117] Y. Rikihisa,et al. Two Monoclonal Antibodies with Defined Epitopes of P44 Major Surface Proteins Neutralize Anaplasma phagocytophilum by Distinct Mechanisms , 2006, Infection and Immunity.
[118] I. Khan,et al. Toxoplasma gondii: a monoclonal antibody that inhibits intracellular replication. , 1994, Experimental parasitology.
[119] A. Camilli,et al. Mucosal Immunization with Vibrio cholerae Outer Membrane Vesicles Provides Maternal Protection Mediated by Antilipopolysaccharide Antibodies That Inhibit Bacterial Motility , 2010, Infection and Immunity.
[120] R. M. Vejborg,et al. Prevention of bacterial adhesion , 2010, Applied Microbiology and Biotechnology.
[121] A. Casadevall,et al. Mechanism for the Isotype Dependence of Antibody-Mediated Toxicity in Cryptococcus neoformans-Infected Mice1 , 2000, The Journal of Immunology.
[122] L. Eckmann. Mucosal defences against Giardia , 2003, Parasite immunology.
[123] J. F. Albright,et al. Antibody‐facilitated macrophage killing of Trypanosoma musculi is an extracellular process as studied in several variations Of an in vitro analytical system , 1994, Journal of leukocyte biology.
[124] W. Otieno,et al. Reduced Immune Complex Binding Capacity and Increased Complement Susceptibility of Red Cells from Children with Severe Malaria-Associated Anemia , 2008, Molecular medicine.
[125] H. Rotman,et al. Immunity to a challenge infection of Strongyloides stercoralis third‐stage larvae in the jird , 1995, Parasite immunology (Print).
[126] M. Walport. Complement. First of two parts. , 2001, The New England journal of medicine.
[127] L. Joosten,et al. Complement plays a central role in Candida albicans‐induced cytokine production by human PBMCs , 2012, European journal of immunology.
[128] C. Newbold,et al. Protection by alpha-thalassaemia against Plasmodium falciparum malaria: modified surface antigen expression rather than impaired growth or cytoadherence. , 1991, Immunology letters.
[129] R. Macdermott,et al. Antibody-dependent cell-mediated antibacterial activity of human mononuclear cells. I. K lymphocytes and monocytes are effective against meningococi in cooperation with human imune sera , 1979, The Journal of experimental medicine.
[130] H. Greenberg,et al. Rotavirus Anti-VP6 Secretory Immunoglobulin A Contributes to Protection via Intracellular Neutralization but Not via Immune Exclusion , 2006, Journal of Virology.
[131] J. Takala,et al. A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[132] T. Mayadas,et al. Human neutrophil Fcgamma receptors initiate and play specialized nonredundant roles in antibody-mediated inflammatory diseases. , 2008, Immunity.
[133] F. Lunel,et al. Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages , 1995, The Journal of Experimental Medicine.
[134] R Möllby,et al. Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli. , 2000, The Journal of infectious diseases.
[135] T. Pierson,et al. Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection , 2008, Expert Reviews in Molecular Medicine.
[136] Minoru Fukuda,et al. Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis , 2008, Nature Medicine.
[137] K. McCullough,et al. Conformational alteration in foot-and-mouth disease virus virion capsid structure after complexing with monospecific antibody. , 1987, Immunology.
[138] I. Goldstein,et al. Characterization of polymorphic forms of Fc receptor III on human neutrophils. , 1989, The Journal of clinical investigation.
[139] T. Hope,et al. New paradigms for functional HIV-specific nonneutralizing antibodies. , 2013, Current opinion in HIV and AIDS.
[140] J. Michl,et al. Neutrophils do not bind to or phagocytize human immune complexes formed with influenza virus. , 1993, Blood.
[141] D. Golenbock,et al. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. , 2005, The Journal of clinical investigation.
[142] R. A. Nelson. The immune-adherence phenomenon; an immunologically specific reaction between microorganisms and erythrocytes leading to enhanced phagocytosis. , 1953, Science.
[143] F. Ennis,et al. Complement-Dependent Lysis of Influenza A Virus-Infected Cells by Broadly Cross-Reactive Human Monoclonal Antibodies , 2011, Journal of Virology.
[144] Y. Xu,et al. Protective immunity induced by the full-length cDNA encoding paramyosin of Chinese Schistosoma japonicum. , 2000, Vaccine.
[145] Arturo Casadevall,et al. CR3 (CD11b/CD18) and CR4 (CD11c/CD18) are involved in complement-independent antibody-mediated phagocytosis of Cryptococcus neoformans. , 2002, Immunity.
[146] Samir N. Patel,et al. C5 deficiency and C5a or C5aR blockade protects against cerebral malaria , 2008, The Journal of experimental medicine.
[147] C. Dupont,et al. Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dIgA or IgM. , 1998, Immunity.
[148] C. Juárez,et al. Relevance of genetically determined host factors to the prognosis of meningococcal disease , 2004, European Journal of Clinical Microbiology and Infectious Diseases.
[149] A. Holder,et al. Immunization against blood-stage rodent malaria using purified parasite antigens , 1981, Nature.
[150] P. Lydyard,et al. Induction of tumor necrosis factor α production by adhered human monocytes: A key role for Fcγ receptor type IIIA in rheumatoid arthritis , 2000 .
[151] A. A. Reeder,et al. Antibody-dependent cell-mediated antibacterial activity: K lymphocytes, monocytes, and granulocytes are effective against shigella. , 1980, Journal of immunology.
[152] S. Alonso,et al. Release of Arachidonic Acid by Stimulation of Opsonic Receptors in Human Monocytes , 2003, Journal of Biological Chemistry.
[153] R. Tesh,et al. Poorly Neutralizing Cross-Reactive Antibodies against the Fusion Loop of West Nile Virus Envelope Protein Protect In Vivo via Fcγ Receptor and Complement-Dependent Effector Mechanisms , 2011, Journal of Virology.
[154] Shibo Jiang,et al. Binding of the 2F5 Monoclonal Antibody to Native and Fusion-Intermediate Forms of Human Immunodeficiency Virus Type 1 gp41: Implications for Fusion-Inducing Conformational Changes , 2004, Journal of Virology.
[155] H. Farrell,et al. Protection against murine cytomegalovirus infection by passive transfer of neutralizing and non-neutralizing monoclonal antibodies. , 1991, The Journal of general virology.
[156] S. Ram,et al. Infections of People with Complement Deficiencies and Patients Who Have Undergone Splenectomy , 2010, Clinical Microbiology Reviews.
[157] L. Pirofski,et al. A Serotype 3 Pneumococcal Capsular Polysaccharide-Specific Monoclonal Antibody Requires Fcγ Receptor III and Macrophages To Mediate Protection against Pneumococcal Pneumonia in Mice , 2012, Infection and Immunity.
[158] S. Costantino,et al. Immune killing of newborn Trichinella larvae by human leucocytes , 1993, Parasite immunology.
[159] V. Vedham,et al. Anti-Peptidoglycan Antibodies and Fcγ Receptors Are the Key Mediators of Inflammation in Gram-Positive Sepsis , 2012, The Journal of Immunology.
[160] J. Köhl,et al. C5a Initiates the Inflammatory Cascade in Immune Complex Peritonitis1 , 2004, The Journal of Immunology.
[161] P. Stewart,et al. Recent structural solutions for antibody neutralization of viruses. , 1997, Trends in microbiology.
[162] H. Snippe,et al. The role of complement in monoclonal antibody-mediated protection against virulent Semliki Forest virus. , 1986, Immunology.
[163] H. Fujisawa. Neutrophils Play an Essential Role in Cooperation with Antibody in both Protection against and Recovery from Pulmonary Infection with Influenza Virus in Mice , 2008, Journal of Virology.
[164] W. Dominic. Owuor BO, Odhiambo CO, Otieno WO, Adhiambo C, Makawiti DW, Stoute JA.Reduced immune complex binding capacity and increased complement susceptibility of red cells from children with severe malaria-associated anemia.Mol Med. 2008 Mar-Apr;14(3-4):89-97 , 2008 .
[165] P. Bruhns,et al. Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. , 2009, Blood.
[166] A. Capron,et al. High-affinity IgE receptor on eosinophils is involved in defence against parasites , 1994, Nature.
[167] M. Horwitz,et al. Interaction of the legionnaires' disease bacterium (legionella pneumophila) with human phagocytes. I. L. pneumophila resists killing by polymorphonuclearleukocytes, antibody, and complement , 1981, The Journal of experimental medicine.
[168] R. Lawrence. Immunity to filarial nematodes. , 2001, Veterinary parasitology.
[169] D. Kabat,et al. Kinetic mechanism for HIV-1 neutralization by antibody 2G12 entails reversible glycan binding that slows cell entry , 2012, Proceedings of the National Academy of Sciences.
[170] J. Burnie,et al. Evaluation of Mycograb, amphotericin B, caspofungin, and fluconazole in combination against Cryptococcus neoformans by checkerboard and time-kill methodologies. , 2005, Diagnostic microbiology and infectious disease.
[171] Y. Ishii,et al. Inhibition of nuclear entry of HPV16 pseudovirus-packaged DNA by an anti-HPV16 L2 neutralizing antibody. , 2010, Virology.
[172] A. Casadevall,et al. Monoclonal antibodies can affect complement deposition on the capsule of the pathogenic fungus Cryptococcus neoformans by both classical pathway activation and steric hindrance , 2006, Cellular microbiology.
[173] L. Presta,et al. Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human FcγRIII and Antibody-dependent Cellular Toxicity* , 2002, The Journal of Biological Chemistry.
[174] F. Galdiero,et al. Cytotoxic antibody dependent cells in mice experimentally infected with Brucella abortus. , 1985, Microbiologica.
[175] A. Lux,et al. Impact of differential glycosylation on IgG activity. , 2011, Advances in experimental medicine and biology.
[176] D. Filman,et al. Structure of the complex between the Fab fragment of a neutralizing antibody for type 1 poliovirus and its viral epitope , 1995, Nature Structural Biology.
[177] A. Casadevall,et al. Review Immunoglobulins in Defense, Pathogenesis, and Therapy of Fungal Diseases , 2022 .
[178] C. Juárez,et al. Associations between Fc gamma receptor IIA polymorphisms and the risk and prognosis of meningococcal disease. , 2002, The American journal of medicine.
[179] T. Hartung,et al. Internalization and Coreceptor Expression Are Critical for TLR2-Mediated Recognition of Lipoteichoic Acid in Human Peripheral Blood , 2010, The Journal of Immunology.
[180] A. Capron,et al. Immunity in human schistosomiasis mansoni. Regulation of protective immune mechanisms by IgM blocking antibodies , 1986, The Journal of experimental medicine.
[181] D. Broide,et al. A comparison of C3a and C5a-mediated stable adhesion of rolling eosinophils in postcapillary venules and transendothelial migration in vitro and in vivo. , 1999, Journal of immunology.
[182] T. Out,et al. The role of Fcγ receptor polymorphisms and C3 in the immune defence against Neisseria meningitidis in complement‐deficient individuals , 2000, Clinical and experimental immunology.
[183] Huimin Yan,et al. Multiple Functions of Immunoglobulin A in Mucosal Defense against Viruses: an In Vitro Measles Virus Model , 2002, Journal of Virology.
[184] E. G. Westaway,et al. A multi-hit model for the neutralization of animal viruses. , 1978, The Journal of general virology.
[185] S. Khusmith,et al. Cooperation between antibodies and monocytes that inhibit in vitro proliferation of Plasmodium falciparum , 1983, Infection and immunity.
[186] T. Takai. Roles of Fc receptors in autoimmunity , 2002, Nature Reviews Immunology.
[187] N. Stollman,et al. Molecular basis for a polymorphism involving Fc receptor II on human monocytes. , 1989, Journal of immunology.
[188] R. S. MacGill,et al. Complement Is Essential for Protection by an IgM and an IgG3 Monoclonal Antibody Against Experimental, Hematogenously Disseminated Candidiasis1 , 2001, Journal of Immunology.
[189] Kenneth G. C. Smith,et al. FcγRIIb Balances Efficient Pathogen Clearance and the Cytokine-mediated Consequences of Sepsis , 2004, The Journal of experimental medicine.
[190] C. García-Rodríguez,et al. Activation of monocytic cells through Fc gamma receptors induces the expression of macrophage-inflammatory protein (MIP)-1 alpha, MIP-1 beta, and RANTES. , 2002, Journal of immunology.
[191] T. Clark,et al. Passive immunization of channel catfish (Ictalurus punctatus) against the ciliated protozoan parasite Ichthyophthirius multifiliis by use of murine monoclonal antibodies , 1996, Infection and immunity.
[192] D. Granoff. Relative importance of complement-mediated bactericidal and opsonic activity for protection against meningococcal disease. , 2009, Vaccine.
[193] John P. Moore,et al. How can HIV-type-1-Env immunogenicity be improved to facilitate antibody-based vaccine development? , 2012, AIDS research and human retroviruses.
[194] H. Greenberg,et al. Antibodies to the trypsin cleavage peptide VP8 neutralize rotavirus by inhibiting binding of virions to target cells in culture , 1991, Journal of virology.
[195] A. Alonso,et al. The expression of cytokine‐induced neutrophil chemoattractants (CINC‐1 and CINC‐2) in rat peritoneal macrophages is triggered by Fcγ receptor activation: Study of the signaling mechanism , 1996, European journal of immunology.
[196] L. Lanier,et al. Immune inhibitory receptors. , 2000, Science.
[197] P. Kaye,et al. Natural antibodies and complement are endogenous adjuvants for vaccine-induced CD8+ T-cell responses , 2003, Nature Medicine.
[198] R. Sandeman,et al. Antibody‐dependent cell‐mediated cytotoxicity to newly excysted juvenile Fasciola hepatica in vitro is mediated by reactive nitrogen intermediates , 2001, Parasite immunology.
[199] K. Yoshino,et al. STUDIES ON THE NEUTRALIZATION OF HERPES SIMPLEX VIRUS. I. APPEARANCE OF NEUTRALIZING ANTIBODIES HAVING DIFFERENT GRADES OF COMPLEMENT REQUIREMENT. , 1965, Virology.
[200] Johannes S. Gach,et al. Fc-Glycosylation Influences Fcγ Receptor Binding and Cell-Mediated Anti-HIV Activity of Monoclonal Antibody 2G12 , 2010, The Journal of Immunology.
[201] G. Landucci,et al. Interactions between Natural Killer Cells and Antibody Fc Result in Enhanced Antibody Neutralization of Human Immunodeficiency Virus Type 1 , 2005, Journal of Virology.
[202] J. L. Nieva,et al. Recognition and Blocking of HIV-1 gp41 Pre-transmembrane Sequence by Monoclonal 4E10 Antibody in a Raft-like Membrane Environment* , 2006, Journal of Biological Chemistry.
[203] M. Carroll,et al. Natural Antibody and Complement Mediate Neutralization of Influenza Virus in the Absence of Prior Immunity , 2007, Journal of Virology.
[204] A. Thomas,et al. Relationship between poliovirus neutralization and aggregation , 1986, Journal of virology.
[205] S. Langermann,et al. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. , 1997, Science.
[206] A. Nisalak,et al. Antibodies that block virus attachment to vero cells are a major component of the human neutralizing antibody response against dengue virus type 2 , 1995, Journal of medical virology.
[207] M. Kazanji,et al. In vitro interactions between murine neutrophils and Eimeria falciformis sporozoites. , 1992, Research in immunology.
[208] J. Jacobson,et al. Ibalizumab: an anti-CD4 monoclonal antibody for the treatment of HIV-1 infection. , 2010, The Journal of antimicrobial chemotherapy.
[209] L. Pirofski,et al. Antifungal Activity of a Human Antiglucuronoxylomannan Antibody , 1998, Clinical Diagnostic Laboratory Immunology.
[210] T. Out,et al. Role of neutrophil Fc gamma RIIa (CD32) and Fc gamma RIIIb (CD16) polymorphic forms in phagocytosis of human IgG1- and IgG3-opsonized bacteria and erythrocytes. , 1994, Immunology.
[211] J. Kinet,et al. Critical role of the neutrophil-associated high-affinity receptor for IgE in the pathogenesis of experimental cerebral malaria , 2011, The Journal of experimental medicine.
[212] L. Schlesinger,et al. Binding of the terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages. , 1994, Journal of immunology.
[213] A. Capron. Schistosomiasis: forty years' war on the worm. , 1998, Parasitology Today.
[214] G. Blobel,et al. Site-specific antibodies against the PrlA (secY) protein of Escherichia coli inhibit protein export by interfering with plasma membrane binding of preproteins. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[215] J. Chen,et al. Ligation of Fc gamma receptor IIB enhances levels of antiviral cytokine in response to PRRSV infection in vitro. , 2012, Veterinary microbiology.
[216] O. Ogunremi,et al. CR3 (CD11b/CD18) is the major macrophage receptor for IgM antibody-mediated phagocytosis of African trypanosomes: diverse effect on subsequent synthesis of tumor necrosis factor alpha and nitric oxide. , 2006, Microbes and infection.
[217] M. Dierich,et al. Complement-HIV interactions during all steps of viral pathogenesis. , 2008, Vaccine.
[218] Deming Zhao,et al. Intracellular neutralization of viral infection in polarized epithelial cells by neonatal Fc receptor (FcRn)-mediated IgG transport , 2011, Proceedings of the National Academy of Sciences.
[219] P. Hogarth,et al. Recombinant soluble human Fc gamma RII: production, characterization, and inhibition of the Arthus reaction , 1993, The Journal of experimental medicine.
[220] S. Iida,et al. A Nonfucosylated Variant of the anti-HIV-1 Monoclonal Antibody b12 Has Enhanced FcγRIIIa-Mediated Antiviral Activity In Vitro but Does Not Improve Protection against Mucosal SHIV Challenge in Macaques , 2012, Journal of Virology.
[221] W. Levinson,et al. Complement components required for virus neutralization by early immunoglobulin antibody. , 1969, Proceedings of the National Academy of Sciences of the United States of America.
[222] Q. Sattentau,et al. Occupancy and mechanism in antibody-mediated neutralization of animal viruses. , 2002, The Journal of general virology.
[223] D. Negrão-Corrêa,et al. Importance of immunoglobulin E (IgE) in the protective mechanism against gastrointestinal nematode infection: looking at the intestinal mucosae. , 2001, Revista do Instituto de Medicina Tropical de Sao Paulo.
[224] Yuxian He,et al. The Epitope and Neutralization Mechanism of AVFluIgG01, a Broad-Reactive Human Monoclonal Antibody against H5N1 Influenza Virus , 2012, PloS one.
[225] T. Kurosaki,et al. SHIP recruitment attenuates Fc gamma RIIB-induced B cell apoptosis. , 1999, Immunity.
[226] E Kohli,et al. Antibody inhibition of the transcriptase activity of the rotavirus DLP: a structural view. , 2001, Journal of molecular biology.
[227] R. Lamb,et al. Effects of antibody to the influenza A virus M2 protein on M2 surface expression and virus assembly. , 1995, Virology.
[228] M. Tanner,et al. Studies on Dipetalonema viteae (Filarioidea) 3. Antibody-dependent cell-mediated destruction of microfilariae in vivo. , 1979, Tropenmedizin und Parasitologie.
[229] S. Jancar,et al. Immune complex-mediated tissue injury: a multistep paradigm. , 2005, Trends in immunology.
[230] T. Kurosaki,et al. SHIP Recruitment Attenuates FcγRIIB-Induced B Cell Apoptosis , 1999 .
[231] L. Lopalco,et al. Induction of Murine Mucosal CCR5-Reactive Antibodies as an Anti-Human Immunodeficiency Virus Strategy , 2005, Journal of Virology.
[232] M. Viveen,et al. Serum Antibodies Critically Affect Virus-Specific CD4+/CD8+ T Cell Balance during Respiratory Syncytial Virus Infections , 2010, The Journal of Immunology.
[233] T S Baker,et al. Structure of human rhinovirus complexed with Fab fragments from a neutralizing antibody , 1993, Journal of virology.
[234] A. Casadevall,et al. Ab binding alters gene expression in Cryptococcus neoformans and directly modulates fungal metabolism. , 2010, The Journal of clinical investigation.
[235] T. Out,et al. Fcã Receptor Iia (Cd32) Polymorphism In Fulminant Meningococcal Septic , 1994 .
[236] Gira Bhabha,et al. Antibody Recognition of a Highly Conserved Influenza Virus Epitope , 2009, Science.
[237] C. Janeway,et al. The complement system and innate immunity , 2001 .
[238] G. Landucci,et al. Rhesus Macaque Polyclonal and Monoclonal Antibodies Inhibit Simian Immunodeficiency Virus in the Presence of Human or Autologous Rhesus Effector Cells , 2006, Journal of Virology.
[239] M. Wong,et al. FcγRIIA polymorphisms in Streptococcus pneumoniae infection , 2003 .
[240] C. Kaetzel,et al. Intracellular neutralization of virus by immunoglobulin A antibodies. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[241] T. Theander,et al. Structural and Functional Insight into How the Plasmodium falciparum VAR2CSA Protein Mediates Binding to Chondroitin Sulfate A in Placental Malaria* , 2012, The Journal of Biological Chemistry.
[242] J. Bunn,et al. Antibodies in Action: Role of Human Opsonins in Killing Salmonella enterica Serovar Typhi , 2011, Infection and Immunity.
[243] I. Bekeredjian-Ding,et al. Staphylococcus aureus-Induced Plasmacytoid Dendritic Cell Activation Is Based on an IgG-Mediated Memory Response1 , 2008, The Journal of Immunology.
[244] R. Carter,et al. Complement-mediated lysis of Plasmodium falciparum gametes by malaria-immune human sera is associated with antibodies to the gamete surface antigen Pfs230 , 1997, Infection and immunity.
[245] B. Eikmanns,et al. The Fibrinogen Receptor FbsA Promotes Adherence of Streptococcus agalactiae to Human Epithelial Cells , 2004, Infection and Immunity.
[246] B. Perussia,et al. Alternative membrane forms of Fc gamma RIII(CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions , 1989, The Journal of experimental medicine.
[247] J. Burnie,et al. Preclinical Assessment of the Efficacy of Mycograb, a Human Recombinant Antibody against Fungal HSP90 , 2003, Antimicrobial Agents and Chemotherapy.
[248] R. Webster,et al. Preparation and properties of antibody directed specifically against the neuraminidase of influenza virus. , 1967, Journal of immunology.
[249] G. Leroux-Roels,et al. Anti‐CD81 antibodies can prevent a hepatitis C virus infection in vivo , 2008, Hepatology.
[250] J. Ravetch,et al. Fcγ receptors as regulators of immune responses , 2008, Nature Reviews Immunology.
[251] L. Lei,et al. Matrix Protein-Specific IgA Antibody Inhibits Measles Virus Replication by Intracellular Neutralization , 2011, Journal of Virology.
[252] H. C. Scott,et al. Differences between the activities of human monoclonal IgG1 and IgG3 anti-D antibodies of the Rh blood group system in their abilities to mediate effector functions of monocytes. , 1988, Immunology.
[253] Z. Bánki,et al. Emerging role for complement in HIV infection. , 2011, Current opinion in HIV and AIDS.
[254] C. Janeway,et al. The destruction of antibody-coated pathogens via Fc receptors , 2001 .
[255] A. Bohbot,et al. Involvement of FcγR I (CD64) in the Mechanism of HIV-1 Inhibition by Polyclonal IgG Purified from Infected Patients in Cultured Monocyte-Derived Macrophages1 , 2004, The Journal of Immunology.
[256] Nancy Haigwood,et al. Human immunodeficiency virus type 1 neutralizing antibodies accelerate clearance of cell–free virions from blood plasma , 1999, Nature Medicine.
[257] A. Casadevall,et al. Murine IgG1 and IgG3 Isotype Switch Variants Promote Phagocytosis of Cryptococcus neoformans through Different Receptors , 2009, The Journal of Immunology.
[258] P. Arese,et al. Enhanced phagocytosis of ring-parasitized mutant erythrocytes: a common mechanism that may explain protection against falciparum malaria in sickle trait and beta-thalassemia trait. , 2004, Blood.
[259] M R Clark,et al. Sequences of complementary DNAs that encode the NA1 and NA2 forms of Fc receptor III on human neutrophils. , 1989, The Journal of clinical investigation.
[260] A. Jegerlehner,et al. Influenza A Vaccine Based on the Extracellular Domain of M2: Weak Protection Mediated via Antibody-Dependent NK Cell Activity , 2004, The Journal of Immunology.
[261] C. Cuffini,et al. Neutralizing monoclonal antibody to the E1 glycoprotein epitope of rubella virus mediates virus arrest in VERO cells. , 2000, Viral immunology.
[262] C. García-Rodríguez,et al. Activation of Monocytic Cells Through Fcγ Receptors Induces the Expression of Macrophage-Inflammatory Protein (MIP)-1α, MIP-1β, and RANTES1 , 2002, The Journal of Immunology.
[263] H. Lyerly,et al. Anti-GP 120 antibodies from HIV seropositive individuals mediate broadly reactive anti-HIV ADCC. , 1987, AIDS research and human retroviruses.
[264] T. Horii,et al. Complement-mediated killing of Plasmodium falciparum erythrocytic schizont with antibodies to the recombinant serine repeat antigen (SERA). , 1998, Vaccine.
[265] A. Glenny,et al. Duration of Passive Immunity , 1922, Journal of Hygiene.
[266] J. Schmitz,et al. Antibody-dependent complement-mediated cytotoxicity in sera from patients with HIV-1 infection is controlled by CD55 and CD59. , 1995, The Journal of clinical investigation.
[267] C. Mold,et al. Protection from Streptococcus pneumoniae Infection by C-Reactive Protein and Natural Antibody Requires Complement But Not Fcγ Receptors1 , 2002, The Journal of Immunology.
[268] P. D. Smith,et al. Human host response to Giardia lamblia. II. Antibody-dependent killing in vitro. , 1983, Cellular immunology.
[269] L. Presta,et al. Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets , 2000, Nature Medicine.
[270] A. Halstensen,et al. FcγRIIa and FcγRIIIb polymorphisms were not associated with meningococcal disease in Western Norway , 2003, Epidemiology and Infection.
[271] R. Chandrashekar,et al. Characterization of a monoclonal antibody against infective larvae of Brugia malayi. , 1988, Immunology.
[272] E. Unanue,et al. Intracellular antibody neutralizes Listeria growth. , 2001, Immunity.
[273] Wutian Wu,et al. Human γδ T Cells: A Lymphoid Lineage Cell Capable of Professional Phagocytosis1 , 2009, The Journal of Immunology.
[274] A. Siddiqui,et al. Role of antibody dependent cell mediated cytotoxicity (ADCC) in Sm-p80-mediated protection against Schistosoma mansoni. , 2012, Vaccine.
[275] Y. Rikihisa,et al. Presence of parasite antigen on the surface of P388D1 cells infected with Ehrlichia risticii , 1992, Infection and immunity.